AGP Picks
View all

European Globe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Globe.

Press releases published on September 30, 2026

SK pharmteco annonce un investissement de plus de 200 millions de dollars aux États-Unis pour renforcer ses capacités de production de petites molécules et de peptides
SK pharmteco, 저분자 의약품·펩타이드 생산능력 확대 위해 미국에 2억 달러 이상 투자 추진
International Petroleum Corporation Updated Share Capital
Shufti Launches Geolocation Compliance to Close the Gap Between Who a Player Is and Where They Are Allowed to Play
Flame Diet App Launches Personalized Anti-Inflammatory Diet
Top Shower Heads Manufacturer Expands Modern Bathroom Water Solutions
KFSH Becomes First Institution in the Middle East to Join International Dementia Registry
OxyCon 2026: Experts Warn the Open Web Is Closing, Just When It Matters Most
Top Crystal Ornament Manufacturer Expands Decorative Glass Solutions for Global Markets
WiseTech Global and World Freight Company connect ATC Aviation GSSA network to CargoWise AirlineConnect
NODES to Lead Sparkling’s International Marketing as Exclusive Partner
Art Share 002 (ARTX: BAC1EU) Announces Delay in Annual Report Publication
Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo’s Board of Directors in January 2027
RedCloud Reports Financial Results for the Six Months Ended June 30, 2026 and Provides Operational Update
SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity
King Faisal Specialist Hospital Foundation and Al Jomaih Foundation Sign Agreement to Establish Stroke Unit
Dune report finds tokenized markets often diverge from the assets they reference
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
TomaGold Continues to Intersect Wide Zones of Zinc, Gold and Silver on Globex Royalty Claims
Highlight Therapeutics Presents Positive Phase 2b Topline Results of Intralesional BO-112 in Localized Basal Cell Carcinoma as a Late-Breaker at EADV

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European Globe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.